0001209191-13-038172.txt : 20130729
0001209191-13-038172.hdr.sgml : 20130729
20130729163340
ACCESSION NUMBER: 0001209191-13-038172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130725
FILED AS OF DATE: 20130729
DATE AS OF CHANGE: 20130729
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 13992878
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-07-25
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
SVP & Corp Controller
Common Stock
2013-07-25
4
M
0
1125
48.74
A
12875
D
Common Stock
2013-07-25
4
S
0
100
84.38
D
12775
D
Common Stock
2013-07-25
4
S
0
542
86.17
D
12233
D
Common Stock
2013-07-25
4
S
0
483
87.29
D
11750
D
Common Stock
169
I
401(k)
Stock Option
48.74
2013-07-25
4
M
0
1125
0.00
D
2022-07-24
Common Stock
1125
13500
D
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $86.17 (range $85.74 to $86.61).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $87.29 (range $87.16 to $87.38).
The option vests in 16 quarterly installments from 07/25/2012.
Kenneth L. Horton, Attorney-In-Fact
2013-07-29